カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界のデシタビン市場2022年：10Mg剤形、15Mg剤形、25Mg剤形

◆英語タイトル：Global Decitabine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY8783 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：112 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

デシタビン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のデシタビンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

デシタビン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・10Mg剤形、15Mg剤形、25Mg剤形

用途別セグメントは次のように区分されます。
・プライマリMDS、セカンダリMDS

世界のデシタビン市場の主要な市場プレーヤーは以下のとおりです。
・Johnson & Johnson、Eli Lilly and Company、Pharmachemie B.V.、Otsuka Pharmaceutical、Sandoz、Dr Reddy's Laboratories、Accord Healthcare、Sun Pharmaceutical、Cipla、Lupin、Shandong Xinshidai Pharmaceutical、Hangzhou Zhongmei Huadong Pharmaceutical、ZHENGDA Tianqing Pharmaceutical Group、Jiangsu Aosaikang Pharmaceutical、Jiangsu Haosen Pharmaceutical Group、Lianyungang Jierui Pharmaceutical、Qilu Pharmaceutical Hainan、Lianyungang Runzhong Pharmaceutical

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、デシタビン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なデシタビンメーカーの企業概要、2019年～2022年までのデシタビンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なデシタビンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別デシタビンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのデシタビンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのデシタビン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびデシタビンの産業チェーンを掲載しています。
・第13、14、15章では、デシタビンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Johnson & Johnson、Eli Lilly and Company、Pharmachemie B.V.、Otsuka Pharmaceutical、Sandoz、Dr Reddy's Laboratories、Accord Healthcare、Sun Pharmaceutical、Cipla、Lupin、Shandong Xinshidai Pharmaceutical、Hangzhou Zhongmei Huadong Pharmaceutical、ZHENGDA Tianqing Pharmaceutical Group、Jiangsu Aosaikang Pharmaceutical、Jiangsu Haosen Pharmaceutical Group、Lianyungang Jierui Pharmaceutical、Qilu Pharmaceutical Hainan、Lianyungang Runzhong Pharmaceutical
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：10Mg剤形、15Mg剤形、25Mg剤形
・用途別分析2017年-2028年：プライマリMDS、セカンダリMDS
・デシタビンの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・デシタビンのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・デシタビンのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・デシタビンの南米市場規模2017年-2028年：ブラジル、アルゼンチン
・デシタビンの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Decitabine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Decitabine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Primary MDS accounting for % of the Decitabine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 10 Mg Dosage Forms segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Decitabine include Johnson & Johnson, Eli Lilly and Company, Pharmachemie B.V., Otsuka Pharmaceutical, and Sandoz, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Decitabine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
10 Mg Dosage Forms
15 Mg Dosage Forms
25 Mg Dosage Forms
Market segment by Application can be divided into
Primary MDS
Secondary MDS
The key market players for global Decitabine market are listed below:
Johnson & Johnson
Eli Lilly and Company
Pharmachemie B.V.
Otsuka Pharmaceutical
Sandoz
Dr Reddy’s Laboratories
Accord Healthcare
Sun Pharmaceutical
Cipla
Lupin
Shandong Xinshidai Pharmaceutical
Hangzhou Zhongmei Huadong Pharmaceutical
ZHENGDA Tianqing Pharmaceutical Group
Jiangsu Aosaikang Pharmaceutical
Jiangsu Haosen Pharmaceutical Group
Lianyungang Jierui Pharmaceutical
Qilu Pharmaceutical Hainan
Lianyungang Runzhong Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Decitabine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Decitabine, with price, sales, revenue and global market share of Decitabine from 2019 to 2022.
Chapter 3, the Decitabine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Decitabine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Decitabine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Decitabine.
Chapter 13, 14, and 15, to describe Decitabine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Decitabine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Decitabine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 10 Mg Dosage Forms
1.2.3 15 Mg Dosage Forms
1.2.4 25 Mg Dosage Forms
1.3 Market Analysis by Application
1.3.1 Overview: Global Decitabine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Primary MDS
1.3.3 Secondary MDS
1.4 Global Decitabine Market Size & Forecast
1.4.1 Global Decitabine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Decitabine Sales in Volume (2017-2028)
1.4.3 Global Decitabine Price (2017-2028)
1.5 Global Decitabine Production Capacity Analysis
1.5.1 Global Decitabine Total Production Capacity (2017-2028)
1.5.2 Global Decitabine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Decitabine Market Drivers
1.6.2 Decitabine Market Restraints
1.6.3 Decitabine Trends Analysis
2 Manufacturers Profiles
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson Decitabine Product and Services
2.1.4 Johnson & Johnson Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Eli Lilly and Company
2.2.1 Eli Lilly and Company Details
2.2.2 Eli Lilly and Company Major Business
2.2.3 Eli Lilly and Company Decitabine Product and Services
2.2.4 Eli Lilly and Company Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Pharmachemie B.V.
2.3.1 Pharmachemie B.V. Details
2.3.2 Pharmachemie B.V. Major Business
2.3.3 Pharmachemie B.V. Decitabine Product and Services
2.3.4 Pharmachemie B.V. Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Otsuka Pharmaceutical
2.4.1 Otsuka Pharmaceutical Details
2.4.2 Otsuka Pharmaceutical Major Business
2.4.3 Otsuka Pharmaceutical Decitabine Product and Services
2.4.4 Otsuka Pharmaceutical Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Sandoz
2.5.1 Sandoz Details
2.5.2 Sandoz Major Business
2.5.3 Sandoz Decitabine Product and Services
2.5.4 Sandoz Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Dr Reddy’s Laboratories
2.6.1 Dr Reddy’s Laboratories Details
2.6.2 Dr Reddy’s Laboratories Major Business
2.6.3 Dr Reddy’s Laboratories Decitabine Product and Services
2.6.4 Dr Reddy’s Laboratories Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Accord Healthcare
2.7.1 Accord Healthcare Details
2.7.2 Accord Healthcare Major Business
2.7.3 Accord Healthcare Decitabine Product and Services
2.7.4 Accord Healthcare Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Sun Pharmaceutical
2.8.1 Sun Pharmaceutical Details
2.8.2 Sun Pharmaceutical Major Business
2.8.3 Sun Pharmaceutical Decitabine Product and Services
2.8.4 Sun Pharmaceutical Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Cipla
2.9.1 Cipla Details
2.9.2 Cipla Major Business
2.9.3 Cipla Decitabine Product and Services
2.9.4 Cipla Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Lupin
2.10.1 Lupin Details
2.10.2 Lupin Major Business
2.10.3 Lupin Decitabine Product and Services
2.10.4 Lupin Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Shandong Xinshidai Pharmaceutical
2.11.1 Shandong Xinshidai Pharmaceutical Details
2.11.2 Shandong Xinshidai Pharmaceutical Major Business
2.11.3 Shandong Xinshidai Pharmaceutical Decitabine Product and Services
2.11.4 Shandong Xinshidai Pharmaceutical Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Hangzhou Zhongmei Huadong Pharmaceutical
2.12.1 Hangzhou Zhongmei Huadong Pharmaceutical Details
2.12.2 Hangzhou Zhongmei Huadong Pharmaceutical Major Business
2.12.3 Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Product and Services
2.12.4 Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 ZHENGDA Tianqing Pharmaceutical Group
2.13.1 ZHENGDA Tianqing Pharmaceutical Group Details
2.13.2 ZHENGDA Tianqing Pharmaceutical Group Major Business
2.13.3 ZHENGDA Tianqing Pharmaceutical Group Decitabine Product and Services
2.13.4 ZHENGDA Tianqing Pharmaceutical Group Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Jiangsu Aosaikang Pharmaceutical
2.14.1 Jiangsu Aosaikang Pharmaceutical Details
2.14.2 Jiangsu Aosaikang Pharmaceutical Major Business
2.14.3 Jiangsu Aosaikang Pharmaceutical Decitabine Product and Services
2.14.4 Jiangsu Aosaikang Pharmaceutical Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Jiangsu Haosen Pharmaceutical Group
2.15.1 Jiangsu Haosen Pharmaceutical Group Details
2.15.2 Jiangsu Haosen Pharmaceutical Group Major Business
2.15.3 Jiangsu Haosen Pharmaceutical Group Decitabine Product and Services
2.15.4 Jiangsu Haosen Pharmaceutical Group Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Lianyungang Jierui Pharmaceutical
2.16.1 Lianyungang Jierui Pharmaceutical Details
2.16.2 Lianyungang Jierui Pharmaceutical Major Business
2.16.3 Lianyungang Jierui Pharmaceutical Decitabine Product and Services
2.16.4 Lianyungang Jierui Pharmaceutical Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Qilu Pharmaceutical Hainan
2.17.1 Qilu Pharmaceutical Hainan Details
2.17.2 Qilu Pharmaceutical Hainan Major Business
2.17.3 Qilu Pharmaceutical Hainan Decitabine Product and Services
2.17.4 Qilu Pharmaceutical Hainan Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Lianyungang Runzhong Pharmaceutical
2.18.1 Lianyungang Runzhong Pharmaceutical Details
2.18.2 Lianyungang Runzhong Pharmaceutical Major Business
2.18.3 Lianyungang Runzhong Pharmaceutical Decitabine Product and Services
2.18.4 Lianyungang Runzhong Pharmaceutical Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Decitabine Breakdown Data by Manufacturer
3.1 Global Decitabine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Decitabine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Decitabine
3.4 Market Concentration Rate
3.4.1 Top 3 Decitabine Manufacturer Market Share in 2021
3.4.2 Top 6 Decitabine Manufacturer Market Share in 2021
3.5 Global Decitabine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Decitabine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Decitabine Market Size by Region
4.1.1 Global Decitabine Sales in Volume by Region (2017-2028)
4.1.2 Global Decitabine Revenue by Region (2017-2028)
4.2 North America Decitabine Revenue (2017-2028)
4.3 Europe Decitabine Revenue (2017-2028)
4.4 Asia-Pacific Decitabine Revenue (2017-2028)
4.5 South America Decitabine Revenue (2017-2028)
4.6 Middle East and Africa Decitabine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Decitabine Sales in Volume by Type (2017-2028)
5.2 Global Decitabine Revenue by Type (2017-2028)
5.3 Global Decitabine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Decitabine Sales in Volume by Application (2017-2028)
6.2 Global Decitabine Revenue by Application (2017-2028)
6.3 Global Decitabine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Decitabine Sales by Type (2017-2028)
7.2 North America Decitabine Sales by Application (2017-2028)
7.3 North America Decitabine Market Size by Country
7.3.1 North America Decitabine Sales in Volume by Country (2017-2028)
7.3.2 North America Decitabine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Decitabine Sales by Type (2017-2028)
8.2 Europe Decitabine Sales by Application (2017-2028)
8.3 Europe Decitabine Market Size by Country
8.3.1 Europe Decitabine Sales in Volume by Country (2017-2028)
8.3.2 Europe Decitabine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Decitabine Sales by Type (2017-2028)
9.2 Asia-Pacific Decitabine Sales by Application (2017-2028)
9.3 Asia-Pacific Decitabine Market Size by Region
9.3.1 Asia-Pacific Decitabine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Decitabine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Decitabine Sales by Type (2017-2028)
10.2 South America Decitabine Sales by Application (2017-2028)
10.3 South America Decitabine Market Size by Country
10.3.1 South America Decitabine Sales in Volume by Country (2017-2028)
10.3.2 South America Decitabine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Decitabine Sales by Type (2017-2028)
11.2 Middle East & Africa Decitabine Sales by Application (2017-2028)
11.3 Middle East & Africa Decitabine Market Size by Country
11.3.1 Middle East & Africa Decitabine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Decitabine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Decitabine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Decitabine
12.3 Decitabine Production Process
12.4 Decitabine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Decitabine Typical Distributors
13.3 Decitabine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Decitabine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Decitabine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 4. Johnson & Johnson Major Business
Table 5. Johnson & Johnson Decitabine Product and Services
Table 6. Johnson & Johnson Decitabine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 8. Eli Lilly and Company Major Business
Table 9. Eli Lilly and Company Decitabine Product and Services
Table 10. Eli Lilly and Company Decitabine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Pharmachemie B.V. Basic Information, Manufacturing Base and Competitors
Table 12. Pharmachemie B.V. Major Business
Table 13. Pharmachemie B.V. Decitabine Product and Services
Table 14. Pharmachemie B.V. Decitabine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Otsuka Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 16. Otsuka Pharmaceutical Major Business
Table 17. Otsuka Pharmaceutical Decitabine Product and Services
Table 18. Otsuka Pharmaceutical Decitabine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Sandoz Basic Information, Manufacturing Base and Competitors
Table 20. Sandoz Major Business
Table 21. Sandoz Decitabine Product and Services
Table 22. Sandoz Decitabine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Dr Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 24. Dr Reddy's Laboratories Major Business
Table 25. Dr Reddy's Laboratories Decitabine Product and Services
Table 26. Dr Reddy's Laboratories Decitabine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Accord Healthcare Basic Information, Manufacturing Base and Competitors
Table 28. Accord Healthcare Major Business
Table 29. Accord Healthcare Decitabine Product and Services
Table 30. Accord Healthcare Decitabine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 32. Sun Pharmaceutical Major Business
Table 33. Sun Pharmaceutical Decitabine Product and Services
Table 34. Sun Pharmaceutical Decitabine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Cipla Basic Information, Manufacturing Base and Competitors
Table 36. Cipla Major Business
Table 37. Cipla Decitabine Product and Services
Table 38. Cipla Decitabine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Lupin Basic Information, Manufacturing Base and Competitors
Table 40. Lupin Major Business
Table 41. Lupin Decitabine Product and Services
Table 42. Lupin Decitabine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Shandong Xinshidai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Shandong Xinshidai Pharmaceutical Major Business
Table 45. Shandong Xinshidai Pharmaceutical Decitabine Product and Services
Table 46. Shandong Xinshidai Pharmaceutical Decitabine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Hangzhou Zhongmei Huadong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 48. Hangzhou Zhongmei Huadong Pharmaceutical Major Business
Table 49. Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Product and Services
Table 50. Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. ZHENGDA Tianqing Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 52. ZHENGDA Tianqing Pharmaceutical Group Major Business
Table 53. ZHENGDA Tianqing Pharmaceutical Group Decitabine Product and Services
Table 54. ZHENGDA Tianqing Pharmaceutical Group Decitabine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Jiangsu Aosaikang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 56. Jiangsu Aosaikang Pharmaceutical Major Business
Table 57. Jiangsu Aosaikang Pharmaceutical Decitabine Product and Services
Table 58. Jiangsu Aosaikang Pharmaceutical Decitabine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Jiangsu Haosen Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 60. Jiangsu Haosen Pharmaceutical Group Major Business
Table 61. Jiangsu Haosen Pharmaceutical Group Decitabine Product and Services
Table 62. Jiangsu Haosen Pharmaceutical Group Decitabine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Lianyungang Jierui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 64. Lianyungang Jierui Pharmaceutical Major Business
Table 65. Lianyungang Jierui Pharmaceutical Decitabine Product and Services
Table 66. Lianyungang Jierui Pharmaceutical Decitabine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Qilu Pharmaceutical Hainan Basic Information, Manufacturing Base and Competitors
Table 68. Qilu Pharmaceutical Hainan Major Business
Table 69. Qilu Pharmaceutical Hainan Decitabine Product and Services
Table 70. Qilu Pharmaceutical Hainan Decitabine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Lianyungang Runzhong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 72. Lianyungang Runzhong Pharmaceutical Major Business
Table 73. Lianyungang Runzhong Pharmaceutical Decitabine Product and Services
Table 74. Lianyungang Runzhong Pharmaceutical Decitabine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Global Decitabine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 76. Global Decitabine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 77. Market Position of Manufacturers in Decitabine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 78. Global Decitabine Production Capacity by Company, (K Units): 2020 VS 2021
Table 79. Head Office and Decitabine Production Site of Key Manufacturer
Table 80. Decitabine New Entrant and Capacity Expansion Plans
Table 81. Decitabine Mergers & Acquisitions in the Past Five Years
Table 82. Global Decitabine Sales by Region (2017-2022) & (K Units)
Table 83. Global Decitabine Sales by Region (2023-2028) & (K Units)
Table 84. Global Decitabine Revenue by Region (2017-2022) & (USD Million)
Table 85. Global Decitabine Revenue by Region (2023-2028) & (USD Million)
Table 86. Global Decitabine Sales by Type (2017-2022) & (K Units)
Table 87. Global Decitabine Sales by Type (2023-2028) & (K Units)
Table 88. Global Decitabine Revenue by Type (2017-2022) & (USD Million)
Table 89. Global Decitabine Revenue by Type (2023-2028) & (USD Million)
Table 90. Global Decitabine Price by Type (2017-2022) & (US$/Unit)
Table 91. Global Decitabine Price by Type (2023-2028) & (US$/Unit)
Table 92. Global Decitabine Sales by Application (2017-2022) & (K Units)
Table 93. Global Decitabine Sales by Application (2023-2028) & (K Units)
Table 94. Global Decitabine Revenue by Application (2017-2022) & (USD Million)
Table 95. Global Decitabine Revenue by Application (2023-2028) & (USD Million)
Table 96. Global Decitabine Price by Application (2017-2022) & (US$/Unit)
Table 97. Global Decitabine Price by Application (2023-2028) & (US$/Unit)
Table 98. North America Decitabine Sales by Country (2017-2022) & (K Units)
Table 99. North America Decitabine Sales by Country (2023-2028) & (K Units)
Table 100. North America Decitabine Revenue by Country (2017-2022) & (USD Million)
Table 101. North America Decitabine Revenue by Country (2023-2028) & (USD Million)
Table 102. North America Decitabine Sales by Type (2017-2022) & (K Units)
Table 103. North America Decitabine Sales by Type (2023-2028) & (K Units)
Table 104. North America Decitabine Sales by Application (2017-2022) & (K Units)
Table 105. North America Decitabine Sales by Application (2023-2028) & (K Units)
Table 106. Europe Decitabine Sales by Country (2017-2022) & (K Units)
Table 107. Europe Decitabine Sales by Country (2023-2028) & (K Units)
Table 108. Europe Decitabine Revenue by Country (2017-2022) & (USD Million)
Table 109. Europe Decitabine Revenue by Country (2023-2028) & (USD Million)
Table 110. Europe Decitabine Sales by Type (2017-2022) & (K Units)
Table 111. Europe Decitabine Sales by Type (2023-2028) & (K Units)
Table 112. Europe Decitabine Sales by Application (2017-2022) & (K Units)
Table 113. Europe Decitabine Sales by Application (2023-2028) & (K Units)
Table 114. Asia-Pacific Decitabine Sales by Region (2017-2022) & (K Units)
Table 115. Asia-Pacific Decitabine Sales by Region (2023-2028) & (K Units)
Table 116. Asia-Pacific Decitabine Revenue by Region (2017-2022) & (USD Million)
Table 117. Asia-Pacific Decitabine Revenue by Region (2023-2028) & (USD Million)
Table 118. Asia-Pacific Decitabine Sales by Type (2017-2022) & (K Units)
Table 119. Asia-Pacific Decitabine Sales by Type (2023-2028) & (K Units)
Table 120. Asia-Pacific Decitabine Sales by Application (2017-2022) & (K Units)
Table 121. Asia-Pacific Decitabine Sales by Application (2023-2028) & (K Units)
Table 122. South America Decitabine Sales by Country (2017-2022) & (K Units)
Table 123. South America Decitabine Sales by Country (2023-2028) & (K Units)
Table 124. South America Decitabine Revenue by Country (2017-2022) & (USD Million)
Table 125. South America Decitabine Revenue by Country (2023-2028) & (USD Million)
Table 126. South America Decitabine Sales by Type (2017-2022) & (K Units)
Table 127. South America Decitabine Sales by Type (2023-2028) & (K Units)
Table 128. South America Decitabine Sales by Application (2017-2022) & (K Units)
Table 129. South America Decitabine Sales by Application (2023-2028) & (K Units)
Table 130. Middle East & Africa Decitabine Sales by Region (2017-2022) & (K Units)
Table 131. Middle East & Africa Decitabine Sales by Region (2023-2028) & (K Units)
Table 132. Middle East & Africa Decitabine Revenue by Region (2017-2022) & (USD Million)
Table 133. Middle East & Africa Decitabine Revenue by Region (2023-2028) & (USD Million)
Table 134. Middle East & Africa Decitabine Sales by Type (2017-2022) & (K Units)
Table 135. Middle East & Africa Decitabine Sales by Type (2023-2028) & (K Units)
Table 136. Middle East & Africa Decitabine Sales by Application (2017-2022) & (K Units)
Table 137. Middle East & Africa Decitabine Sales by Application (2023-2028) & (K Units)
Table 138. Decitabine Raw Material
Table 139. Key Manufacturers of Decitabine Raw Materials
Table 140. Direct Channel Pros & Cons
Table 141. Indirect Channel Pros & Cons
Table 142. Decitabine Typical Distributors
Table 143. Decitabine Typical Customers
List of Figures
Figure 1. Decitabine Picture
Figure 2. Global Decitabine Revenue Market Share by Type in 2021
Figure 3. 10 Mg Dosage Forms
Figure 4. 15 Mg Dosage Forms
Figure 5. 25 Mg Dosage Forms
Figure 6. Global Decitabine Revenue Market Share by Application in 2021
Figure 7. Primary MDS
Figure 8. Secondary MDS
Figure 9. Global Decitabine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Decitabine Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Decitabine Sales (2017-2028) & (K Units)
Figure 12. Global Decitabine Price (2017-2028) & (US$/Unit)
Figure 13. Global Decitabine Production Capacity (2017-2028) & (K Units)
Figure 14. Global Decitabine Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Decitabine Market Drivers
Figure 16. Decitabine Market Restraints
Figure 17. Decitabine Market Trends
Figure 18. Global Decitabine Sales Market Share by Manufacturer in 2021
Figure 19. Global Decitabine Revenue Market Share by Manufacturer in 2021
Figure 20. Decitabine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Decitabine Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Decitabine Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Decitabine Sales Market Share by Region (2017-2028)
Figure 24. Global Decitabine Revenue Market Share by Region (2017-2028)
Figure 25. North America Decitabine Revenue (2017-2028) & (USD Million)
Figure 26. Europe Decitabine Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Decitabine Revenue (2017-2028) & (USD Million)
Figure 28. South America Decitabine Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Decitabine Revenue (2017-2028) & (USD Million)
Figure 30. Global Decitabine Sales Market Share by Type (2017-2028)
Figure 31. Global Decitabine Revenue Market Share by Type (2017-2028)
Figure 32. Global Decitabine Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global Decitabine Sales Market Share by Application (2017-2028)
Figure 34. Global Decitabine Revenue Market Share by Application (2017-2028)
Figure 35. Global Decitabine Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America Decitabine Sales Market Share by Type (2017-2028)
Figure 37. North America Decitabine Sales Market Share by Application (2017-2028)
Figure 38. North America Decitabine Sales Market Share by Country (2017-2028)
Figure 39. North America Decitabine Revenue Market Share by Country (2017-2028)
Figure 40. United States Decitabine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Decitabine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Decitabine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Decitabine Sales Market Share by Type (2017-2028)
Figure 44. Europe Decitabine Sales Market Share by Application (2017-2028)
Figure 45. Europe Decitabine Sales Market Share by Country (2017-2028)
Figure 46. Europe Decitabine Revenue Market Share by Country (2017-2028)
Figure 47. Germany Decitabine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Decitabine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Decitabine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Decitabine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Decitabine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Decitabine Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Decitabine Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Decitabine Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Decitabine Revenue Market Share by Region (2017-2028)
Figure 56. China Decitabine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Decitabine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Decitabine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Decitabine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Decitabine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Decitabine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Decitabine Sales Market Share by Type (2017-2028)
Figure 63. South America Decitabine Sales Market Share by Application (2017-2028)
Figure 64. South America Decitabine Sales Market Share by Country (2017-2028)
Figure 65. South America Decitabine Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Decitabine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Decitabine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Decitabine Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Decitabine Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Decitabine Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Decitabine Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Decitabine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Decitabine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Decitabine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Decitabine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Decitabine in 2021
Figure 77. Manufacturing Process Analysis of Decitabine
Figure 78. Decitabine Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のデシタビン市場2022年：10Mg剤形、15Mg剤形、25Mg剤形(Global Decitabine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のデシタビン市場2022年：10Mg剤形、15Mg剤形、25Mg剤形

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp